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Summary
What is already known about this topic?
Previous electronic referral evaluations focused only on clinical settings
and did not examine differences in referral and completion rates by racial/
ethnic groupings and preferred language.
What is added by this report?
From 2014 through 2017, Massachusetts clinics used electronic referrals
to connect underserved patients to community organizations. Non-
Hispanic black and Hispanic patients had higher odds than non-Hispanic
white patients of receiving a referral, and patients who completed their hy-
pertension intervention had higher odds of controlled blood pressure.
What are the implications for public health practice?
This research demonstrates that electronic referral systems can success-
fully direct referrals to community organizations to address health disparit-
ies and improve health outcomes.
Abstract
Introduction
Massachusetts developed and used bidirectional electronic refer-
rals to connect clinical patients across the state to interventions run
by community organizations. The objective of our study was to
determine whether the use of Massachusetts’s electronic referral
system (MA e-Referral) reached racial/ethnic groups experiencing
health disparities and whether it was associated with improved
health outcomes.
Methods
We assembled encounter-level medical records from September
2013 through June 2017 for patients at Massachusetts clinics fun-
ded by the Clinical Community Partnerships for Prevention into 2
cohorts. First, all patients meeting program eligibility guidelines
for an e-Referral (N = 21,701) were examined to assess the distri-
bution of e-Referrals among populations facing health disparities;
second, a subset of 3,817 people with hypertension were analyzed
to detect changes in blood pressure after e-Referral to an evidence-
based community intervention.
Results
Non-Hispanic  black  (OR,  1.4;  95%  confidence  interval  [CI],
1.2–1.6) and Hispanic patients (OR, 1.3; 95% CI, 1.1–1.4) had
higher odds than non-Hispanic white patients of being referred
electronically. Patients completing their hypertension intervention
had 74% (95% CI, 1.2–2.5) higher odds of having an in-control
blood pressure reading than patients who were not electronically
referred.
Conclusion
Clinical to community linkage to interventions through MA e-Re-
ferral reached non-Hispanic black, Hispanic, and Spanish-speak-
ing populations and was associated with improved blood pressure
control.
Introduction
Racism, classism, sexism, and socioeconomic inequalities prevent
people from achieving good health (1). These conditions create
health disparities — the variation in health outcomes between
groups  that  are  “systematic,  socially  produced  (and  therefore
modifiable), and unfair” (2). Massachusetts created the Preven-
tion and Wellness Trust Fund to address health disparities and im-
prove health outcomes. Nine communities covering 15% of the
Massachusetts population were granted funding under the fund’s
Clinical–Community  Partnerships  for  Prevention  (CCPP)  (3).
These communities had 23% higher rates of hospitalization, great-
er racial/ethnic diversity, more residents living below the poverty
line, and shorter lifespans than the state average (3).
In 2008, Frieden and Mostashari proposed using electronic health
records (EHRs) to achieve health improvements (4). Multiple sites
and countries previously implemented electronic referrals to link
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primary care to specialists (5–11). Studies of electronic referrals to
tobacco cessation services found increased referral rates, uptake of
services, and quit rates relative to other referral methods (12–15).
Current research has not examined whether different racial/ethnic
populations consent at the same rate to electronic referrals, and re-
search is limited on outcomes outside of tobacco use.
In 2013, Massachusetts secured a State Innovation Model Testing
Award from the Centers for Medicare and Medicaid Innovation;
from that award Massachusetts developed the first fully electronic,
bidirectional referral system between clinicians and community re-
sources (16). The Massachusetts e-Referral system deviates from
other electronic referral methods in 2 ways: 1) information moves
in both directions between the referring provider and the receiv-
ing organization, and 2) the organizations receiving referrals are
community-based (16,17). All CCPP partnerships were required to
implement an e-referral system. The objective of our study was to
determine if clinical sites using the MA e-Referral system success-
fully reached racial/ethnic groups experiencing health disparities.
Additionally, our analyses assessed the efficacy of e-Referrals for
community organizations in achieving health improvements.
Methods
Encounter-level health records on all patients at clinics participat-
ing in CCPP were the primary data source. These data are sent
quarterly to the Massachusetts Department of Public Health to
evaluate quality improvement efforts. Each patient is assigned a
random identification number to link records. Information collec-
ted includes diagnosis codes, medications, demographics (such as
self-reported race/ethnicity and preferred language), laboratory
values, and vital signs.
MA e-Referral  data  were  captured  in  a  separate  database  and
matched to the clinical records through an outside agency. Inform-
ation in the MA e-Referral database covered patients referred, the
intervention to which they were referred, and their intervention
progress.  The linked database resulted in a clinical data set  of
more than 4 million records for 430,085 patients for visits from
September 1, 2013, through June 30, 2017; 99% of electronic re-
ferrals were successfully linked to medical records. From this data
set, a retrospective cohort analysis was performed on clinical pa-
tients in the CCPP. The CCPP program and data were determined
to be nonresearch by the Massachusetts  Department  of  Public
Health’s institutional review board.
Each CCPP partnership was required to implement an electronic
referral system in at least 1 clinical site. Ten health center sites
representing 8 of the 9 partnerships (1 partnership invested in its
own electronic referral system) implemented MA e-Referral to
connect their patients (N = 155,454) to 13 evidence-based com-
munity interventions that ranged from self-monitored blood pres-
sure and chronic disease self-management for  hypertension to
home visits for patients at risk for falls (details of interventions are
in the Prevention and Wellness Trust Fund Legislative Report [3]).
Health centers selected which conditions they wanted to address in
their populations. People who received a diagnosis of a condition
eligible for e-Referral (n = 21,701) were separated into those who
were electronically referred (n = 1,866) to any community pro-
gram compared with those not electronically referred (n = 19,835).
Multiple logistic regression models were used to analyze differ-
ences in referral patterns and completion rates by race/ethnicity
and preferred language; 95% confidence intervals were used to es-
tablish significance (Figure 1).
Figure 1. Flowchart of the Massachusetts all e-Referral–eligible cohort and the
Massachusetts  e-Referral  hypertension cohort.  The flowchart  depicts the
progression  of  the  patient  population  from  the  10  Clinical  Community
Partnerships for Prevention (CCPP) Community Health Center sites to the
Massachusetts  all  e-Referral–eligible  cohort  (n  =  21,701)  and  the
Massachusetts e-Referral hypertension cohort (n = 3,817).
The second portion of the analysis focused on determining wheth-
er health improvements were associated with the delivery of com-
munity-based interventions. For these analyses, only people who
had or were eligible for hypertension e-Referrals were examined.
Blood pressure readings emerged as a primary focus of this ana-
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lysis because more patients were referred to community services
for hypertension than for any other health condition. Patients at the
5 sites addressing hypertension who met eligibility criteria for a
hypertension referral on at least 1 visit in the baseline year were
divided into those who were electronically referred versus not
electronically referred (n = 3,817 patients in the Massachusetts hy-
pertension cohort sample). The CCPP eligibility criteria for a hy-
pertension referral were having a recorded hypertension diagnosis
code during the baseline year and 1 or more blood pressure read-
ings during the baseline year that indicated pressure was not un-
der control (≥140/90  mmHg) per JNC 7 (Joint National Commit-
tee on Prevention, Detection, Evaluation, and Treatment of High
Blood Pressure–7) guidelines (3). Those receiving hypertension e-
Referrals (group 1, n = 721) to either self-monitored blood pres-
sure or chronic disease self-management (3) and those who met
the criteria but who were not referred (group 2, n = 3,096) were
compared to assess blood pressure changes over time (Figure 1).
Of  the  721  patients  electronically  referred,  528  lacked  docu-
mented evidence in the e-Referral system of attending at least 1
session of the intervention, 56 individuals were enrolled but did
not complete the intervention, and 137 individuals enrolled and
completed the intervention. The timeframe for these analyses was
individualized to each clinical site: baseline data were defined as
the year leading up to the date of the clinic’s first e-Referral for
hypertension, and intervention data were all post that point. Start
dates  for  hypertension  e-Referrals  ranged from April  through
November 2015. The study population was limited to patients with
at least 1 follow-up visit during the intervention period.
Sex (male, female, other), self-reported race/ethnicity (non-His-
panic white, non-Hispanic black, Hispanic, other), preferred lan-
guage  for  medical  information  (English,  Spanish,  other),  age
group (18–34, 35–54, 55–74, ≥75), and comorbidities (as defined
by the Charlson Comorbidity Index [18,19]) were included in the
hypertension models as covariates. The outcomes were blood pres-
sure control status and systolic readings based on the last docu-
mented blood pressure during the intervention period. Systolic
blood pressure was selected because systolic decreases have a
greater  impact  than  diastolic  decreases  on  improving  cardiac
health outcomes (20–22). These blood pressure readings were ana-
lyzed with a multiple logistic regression model to detect transition
to controlled blood pressure from baseline through the interven-
tion period, and we used a multiple linear regression model to de-
tect millimeters of mercury (mmHg) changes in systolic blood
pressure; 95% confidence intervals were used to establish signific-
ance. SAS version 9.3 (SAS Institute) was used for all analyses
performed.
 
Results
Demographic comparison of referred patients with
other groups
Although Massachusetts residents are 80% non-Hispanic white
and 16% speak a language other than English as the primary lan-
guage at home (3), the demographics of the patient population
seen at the 10 clinical sites indicated that the CCPP clinics reached
a more diverse population. The 155,454 patients were 36.5% non-
Hispanic white, and only slightly more than half preferred to have
medical information presented in English (56.1%) (Table 1). We
performed χ2 tests of independence on both the all e-Referral–eli-
gible cohort and the e-Referral hypertension cohort; the distribu-
tion of demographics in each sample was related to referral status.
E-Referrals were first made in 2014. From 2014 through 2017,
1,866 patients received at least one e-Referral. All race/ethnicity
and language referral analyses controlled for age category, sex,
and Charlson comorbidity presence. Among these referrals, His-
panic patients had 26% higher odds of being electronically re-
ferred than non-Hispanic white patients (95% CI, 1.1–1.4) and
non-Hispanic  black  patients  had  37%  higher  odds  (95%  CI,
1.2–1.6) (Figure 2).
Figure 2. Multiple logistic regression modeling of the odds of receiving and
completing an e-Referral by race/ethnicity and preferred language among
21,701 Massachusetts clinical patients seen from 2013 through 2017. The
multiple logistic regression models examine the odds of referral and the odds
of  completing  an  intervention  by  race/ethnicity  and  preferred  language.
Brackets indicate 95% Wald confidence intervals.  Abbreviation:  NH, non-
Hispanic.
Next, completion rates were examined with logistic regression
models of race/ethnicity and preferred language that controlled for
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age category, sex, and Charlson comorbidity status to determine
whether all groups had the same odds of completing interventions
once they were electronically referred. Completion rates among
Hispanic patients (OR 0.9; 95% CI, 0.7–1.1) and non-Hispanic
black patients (OR 0.8; 95% CI, 0.5–1.2) were not significantly
different from non-Hispanic white patients’ completion rates. By
language, completion rates among Spanish speakers and English
speakers were also not significantly different (OR 0.9; 95% CI,
0.7–1.1) (Figure 2).
Hypertension health outcomes of referred patients
compared with nonreferred patients
A multiple logistic regression model was used to calculate the
odds that an individual maintained or achieved blood pressure
control (<140/90 mmHg) at their last reading during the interven-
tion time period when compared with their last reading during
baseline. During the last visit of the baseline period, 62% of the
nonreferred group had hypertensive blood pressure compared with
58% of the electronically referred group. After controlling for sex,
presence of  comorbidities,  age group,  race/ethnicity,  and pre-
ferred language, patients who were electronically referred (regard-
less  of  the  referral  outcome)  had  66% greater  odds  (95% CI,
1.4–2.0) of maintaining or achieving blood pressure control when
compared with nonreferred patients. Patients who were referred
and  completed  their  program had  74% greater  odds  (95% CI,
1.2–2.5) than nonreferred patients of moving into or maintaining
blood pressure control (Table 2). At the end of the intervention
period, 43% of the nonreferred group had hypertensive blood pres-
sure compared with 33% of the electronically referred group (P <
.01). When controlling for referral and completion status, non-His-
panic black patients had lower odds of achieving blood pressure
control than non-Hispanic white patients, whereas Hispanic pa-
tients and Spanish-speaking patients did not have significantly dif-
ferent rates of control achievement than non-Hispanic white pa-
tients and English-speaking patients (Table 2). All groups saw a
decrease in the percentage of their population with hypertensive
blood pressure readings, but only for Hispanic and non-Hispanic
white patients was the difference in the referred group signific-
antly lower than in the nonreferred group (P < .01 for both).
To determine the extent  of  changes in systolic  blood pressure
readings, the final systolic readings were compared among the
groups in a linear regression. During the last visit of the baseline
period, the nonreferred group had an average systolic blood pres-
sure reading of 139 mmHg, compared with 138 mmHg in the elec-
tronically referred group. After controlling for sex, Charlson co-
morbidities, age group, race/ethnicity, and preferred language, pa-
tients who were referred (regardless of the referral outcome) had a
final systolic blood pressure reading that  was  on  average 3.4
mmHg lower (P < .01) than patients without a referral. When lim-
iting the referral sample to only completers, referred patients who
completed their intervention had a final systolic blood pressure
reading that was on average 3.0 mmHg lower (P = .04) than pa-
tients without a referral (Table 3). At the end of the intervention
period, the nonreferred group had an average systolic blood pres-
sure reading of 134 mmHg compared with 131 mmHg in the elec-
tronically referred group. Non-Hispanic black patients had a high-
er final systolic blood pressure than non-Hispanic white patients.
Hispanic  patients  did  not  have  significantly  different  systolic
blood pressure readings than non-Hispanic white patients, nor did
Spanish-speaking patients  have significantly different  systolic
blood pressure readings than English-speaking patients (Table 3).
All racial/ethnic referred groups, except for non-Hispanic white
patients, saw an average decrease in their systolic blood pressure
readings that was more than double what was observed in their
nonreferred counterparts.
Discussion
Electronic referrals have been found to better ensure the delivery
of referrals, improve documentation, and standardize the referral
format when compared with other referral methods (5–9). Embed-
ding referral information in medical records provided the oppor-
tunity to assess the efficacy of MA e-Referral as a bidirectional re-
ferral  system establishing  clinical  to  community  linkages  (7).
Moreover, MA e-Referral allowed Massachusetts to assess wheth-
er referrals were being directed toward groups experiencing health
disparities. Nationally, hypertension is a prominent health equity
issue. Rates among non-Hispanic black people in the United States
are among the highest worldwide, and this population develops
high blood pressure at younger ages than non-Hispanic white pop-
ulations and has higher average blood pressure levels (23), which
persist even after controlling for socioeconomic status and under-
lying medical conditions (24,25). Our analysis controlled for the
presence of comorbidities, which are correlated with hypertension
rates and cluster in populations to produce some of the hyperten-
sion health disparities (26). People with 1 or more comorbidities
were 30% more likely to have in-control blood pressure.
Promisingly, our analysis found that referrals were successfully
focused on groups facing hypertension health disparities: among
eligible candidates, non-Hispanic black and Hispanic patients had
higher odds of receiving an e-Referral than non-Hispanic white
patients. The MA e-Referral system allowed for examination of
completion rates by race/ethnicity to determine whether e-Refer-
rals led to participation in community programs. Completion rates
by race/ethnicity and language were not significantly different
when compared with non-Hispanic white patients or with English-
speaking patients’ completion rates.
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Both receiving and completing an e-Referral for a community hy-
pertension intervention were found to be correlated with increased
likelihood  of  achieving  blood  pressure  control  and  reducing
systolic blood pressure. The 3.0 mmHg reduction in systolic blood
pressure that referral completers experienced is on par with the re-
ductions seen in many nonpharmacologic interventions promoted
by the 2017 High Blood Pressure Clinical  Practice Guidelines
(26).
This research had some limitations. First, although all clinical sites
received guidelines on how to refer patients, there was flexibility
in guideline application. If patients did not conform to referral cri-
teria, but clinical judgment determined that the program would be
valuable, a referral could be made. Data indicate the guidelines
were typically observed, because 74% of hypertension e-Referral
patients met JNC 7 guidelines before referral. The nonreferred
group, all of whom met JNC 7 guidelines, may not accurately rep-
resent the health status of the electronically referred patients (in
the absence of a referral). Furthermore, the offer of an e-Referral
to patients was not documented in medical records. Because ac-
cepting an e-Referral intervention was voluntary, participating pa-
tients may have been more motivated to make behavior changes to
reduce their hypertension risk beyond intervention participation,
potentially introducing self-selection bias (28). Additionally, our
clinics are relatively homogenous in serving low-income popula-
tions that were racially, ethnically, and linguistically diverse. The
linear modeling outlined in this article was also run as a mixed-ef-
fects model with clinic as a random effect; clinical effect was not
significant. Though it did not affect the model, the unique make-
up of our clinical populations may limit generalizability of the res-
ults. Lastly, the MA e-Referral system was designed to facilitate
communication between clinicians and community service pro-
viders rather than as a data collection system for research. Con-
sequently, we had issues with the standardization of the MA e-Re-
ferral  data for  the term “enrollment.” All  e-Referrals  were re-
viewed by the first author to systematize the classification of en-
rollment as at least 1 session attended. Not all sites were able to
implement e-Referral because of technology or budget limitations
and instead made referrals via paper copies and fax. These refer-
rals were not used in this analysis. However, data collected on all
methods of hypertension referrals to community interventions es-
tablished the enrollment rate at approximately 50% (3). Even after
reclassification, this analysis found only a 27% referral enroll-
ment rate. It is unclear if more patients enrolled than were able to
be identified on the basis of the documentation in the e-Referral
system. Future analyses of the benefits of enrolling (even without
completion) would expand the evidence base around the effective-
ness of these interventions.
Patients completing interventions to which they were referred had
higher odds of transitioning to an in-control blood pressure status
and of experiencing reductions in their overall systolic blood pres-
sure when compared with nonreferred patients with similar demo-
graphic and health profiles. Additionally, e-Referrals were suc-
cessfully directed toward groups facing health disparities,  and
completion rates were not statistically different between groups
after the e-Referral was made. These findings demonstrate the suc-
cessful implementation of the MA e-Referral system as a means to
connect patients to evidence-based interventions to improve hy-
pertension outcomes and of the ability to direct referrals to ad-
dress health disparities, both critical steps toward improved popu-
lation health.
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Tables
Table 1. Characteristics of Patients in the Massachusetts e-Referral Program, September 2013–June 2017a
Variable
All Clinical Patients at
e-Referral Sites (%)
All e-Referral–Eligible Cohort (%) e-Referral Hypertension Cohort (%)
Not Referred Referred Not Referred Referred
Total Population 155,454 (100.0) 19,835 (91.4) 1866 (8.6) 3,096 (81.1) 721 (18.9)
Race/ethnicity
Non-Hispanic black 16,233 (10.4) 2,027 (10.2) 237 (12.7) 379 (12.4) 127 (17.6)
Hispanic 59,000 (38.0) 7,754 (39.1) 918 (49.2) 1,263 (40.8) 390 (54.1)
Non-Hispanic white 56,702 (36.5) 7,375 (37.2) 583 (31.2) 1,096 (35.4) 161 (22.3)
Otherb 23,519 (15.1) 2,679 (13.5) 128 (6.9) 358 (11.6) 43 (6.0)
Sex
Male 68,572 (44.1) 8,937 (45.1) 715 (38.3) 1,599 (51.7) 432 (59.9)
Female 86,874 (55.9) 10,897 (54.9) 1,151 (61.7) 1,497 (48.4) 289 (40.1)
Other 8 (0.0) 1 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Preferred languagec
English 87,218 (56.1) 9,476 (47.8) 878 (47.1) 1,445 (46.7) 354 (49.1)
Spanish 41,495 (26.7) 6,290 (31.7) 783 (42.0) 1,063 (34.3) 338 (46.9)
Other 26,741 (17.2) 4,069 (20.5) 205 (11.0) 588 (19.0) 29 (4.0)
≥1 Charlson comorbidities presentd 34,310 (22.1) 10,465 (52.8) 1,397 (74.9) 2,355 (76.1) 553 (76.7)
Age
0–17 36,378 (23.4) 1,140 (5.8) 77 (4.1) 0 (0.0) 0 (0.0)
18–34 42,143 (27.1) 1,007 (5.1) 121 (6.5) 72 (2.3) 17 (2.4)
35–54 45,757 (29.4) 4,763 (24.0) 504 (27.0) 1,017 (32.9) 245 (34.0)
55–74 27,024 (17.4) 10,032 (50.6) 917 (49.1) 1,675 (54.1) 423 (58.7)
≥75 4,152 (2.7) 2,893 (14.6) 247 (13.2) 332 (10.7) 36 (5.0)
a Percentages may not total 100 because of rounding.
b Includes all patients not classified as non-Hispanic black, Hispanic, or non-Hispanic white.
c The primary language that the patient selects to receive medical information.
d Charlson comorbidity index (18,19).
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Table 2. Comparison of 2 Models for Odds of Blood Pressure Control During the Intervention, Patients in Massachusetts e-Referral Program, September
2013–June 2017a
Variable
Model 1: All Massachusetts e-Referral for Hypertension
Patients and Patients Not e-Referred (n = 3,817), OR (95%
CI)a
Model 2: Patients Completing Massachusetts e-Referral for
Hypertension and Patients Not e-Referred (n = 3,233), OR
(95% CI)a
Race/ethnicity
Non-Hispanic white Reference
Non-Hispanic black 0.7 (0.6–0.9) 0.8 (0.6–1.0)
Hispanic 0.8 (0.6–1.0) 0.9 (0.7–1.2)
Otherb 1.0 (0.8–1.3) 1.0 (0.8–1.4)
Age, y
18–34 Reference
35–54 0.7 (0.4–1.0) 0.6 (0.4–1.0)
55–74 0.8 (0.5–1.2) 0.7 (0.4–1.2)
≥75 0.8 (0.5–1.3) 0.7 (0.4–1.3)
Preferred languagec
English Reference
Other 1.1 (0.9–1.4) 1.1 (0.9–1.4)
Spanish 1.1 (0.9–1.4) 1 (0.8–1.3)
Sex
Male Reference
Female 1.1 (1.0–1.3) 1.1 (1.0–1.3)
Comorbidityd
Absent Reference
Present 1.3 (1.1–1.5) 1.3 (1.1–1.6)
Referral statuse
No referral Reference
Referred 1.7 (1.4–2.0) —f
Completed referral —f 1.7 (1.2–2.5)
Abbreviations: CI, confidence interval; OR, odds ratio.
a Multiple logistic regression model of the odds ratios for last blood pressure transitioning to or remaining in control when compared with baseline blood pressure
in the Massachusetts e-Referral hypertension cohort population. Values are odds ratio and 95% confidence intervals for in-control blood pressure. Wald 95% con-
fidence intervals were used to establish significance.
b Includes all patients not classified as non-Hispanic black, Hispanic, or non-Hispanic white.
c The primary language that the patient selects to receive medical information.
d Defined as the presence of hypertension and 1 or more of the conditions covered by the Charlson comorbidity index (18,19).
e Defined as whether patients received an e-Referral and whether they completed that e-Referral.
f Outcome not applicable for that logistic regression model.
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Table 3. Comparison of Systolic Blood Pressure Measurements During the Intervention, Calculated by Multiple Linear Regression, Patients in Massachusetts e-
Referral Program, April 2015–June 2017
Characteristic
Model 1: All MA e-Referred for Hypertension Patients and
Not e-Referred (n = 3,817)
Model 2: Only Completing MA e-Referral for Hypertension
Patients and Not-e-Referred (n = 3,233)
Mean Change in Systolic
Blood Pressure (mmHg) P Valuea
Mean Change in Systolic
Blood Pressure (mmHg) P Valuea
Race/ethnicity
Non-Hispanic white Reference
Non-Hispanic black 3.2 <.001 3.0 .001
Hispanic 0.9 .38 −0.3 .77
Otherb −0.07 .94 0.4 .73
Age
18–34 Reference
35–54 2.9 .1 3.7 .06
55–74 4.6 .01 5.2 .01
≥75 5.2 .01 5.5 .01
Preferred languagec
English Reference
Other 0.3 .72 0.06 .94
Spanish −0.3 .73 0.7 .52
Sex
Male Reference
Female −1.5 .01 −1.0 .09
Comorbidityd
Absent Reference
Present −1.8 .005 −2.0 .004
Referral statuse
No referral Reference
Referred −3.4 <.001 —f —f
Completed referral —f —f −3.0 .04
a P values calculated by using t test; α level for significance was P < .05.
b Includes all patients not classified as non-Hispanic black, Hispanic, or non-Hispanic white.
c The primary language that the patient selects to receive medical information.
d Defined as the presence of hypertension and 1 or more of the conditions covered by the Charlson comorbidity index (18,19).
e Defined as whether patients received an e-Referral and whether they completed that e-Referral.
f Outcome not applicable for that linear regression model.
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